Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1483-1490

  Baratelli, Felicita ^b   Lin, Ying ^b   Zhu, Li ^b   Yang, Seok Chul ^b   Heuzé Vourc'h, Nathalie ^b   Zeng, Gang ^b   Reckamp, Karen ^b   Dohadwala, Mariam ^b   Sharma, Sherven ^b   Dubinett, Steven M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CYCLOOXYGENASE 2; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR FOXP3; DNA BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CANCER CELL CULTURE; CELL CONTACT; CONTROLLED STUDY; FOXP3 GENE; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LUNG CANCER; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNOLOGY; BIOSYNTHESIS; DRUG EFFECT; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; REGULATORY T LYMPHOCYTE; TUMOR CELL LINE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; CELL LINE, TUMOR; DINOPROSTONE; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JURKAT CELLS; PROMOTER REGIONS (GENETICS); RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 22544436066     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1483     Document Type: Article

References (50)

1. + T regulatory cells. Nat. Immunol. 4: 330-336.
2. + T regulatory cells. Nat. Immunol. 4: 337-342.
3. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor foxp3. Science 299: 1057-1061.
4. + regulatory T cells. Curr. Opin. Immunol. 16: 203-208.
5. + regulatory T cells: thymus or periphery? J. Clin. Invest. 112: 1310-1312.
6. - T cells through foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
7. + regulatory T cells by TGF-β induction of transcription factor foxp3. J. Exp. Med. 198: 1875-1886.
8. - T cells. J. Clin. Invest. 112: 1437-1443.
9. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
10. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99: 2468-2476.
11. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392.
12. - cells. Proc. Natl. Acad. Sci. USA 102: 4103-4108.
13. Harris, S. G., J. Padilla, L. Koumas, D. Ray and R. P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23: 144-150.
14. Stolina, M., S. Sharma, Y. Lin, M. Dohadwala, B. Gardner, J. Luo, L. Zhu, M. Kronenberg, P. W. Miller, J. Portanova, et al. 2000. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol. 164: 361-370.
15. 2 enhance peripheral blood IL-10 transcription and protein production. J. Immunol. 157: 5512-5520.
16. Dubinett, S. M., S. Sharma, M. Huang, M. Dohadwala, M. Pold, and J. Mao. 2003. Cyclooxygenase-2 in lung cancer. In COX-2. A. J. Dannenberg and R. N. DuBois, eds. Karger, Basel, p. 138.
17. Liyanage, U. K., T. T. Moore, H.-G. Joo, Y. Tanaka, V. Hermann, G. Doherty, J. A. Drebin, S. M. Strasberg, T. J. Eberlein, P. S. Goedegebure, et al. 2002. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169: 2756-2761.
18. + regulatory T cells in patients with gastrointestinal malignancies. Cancer 98: 1089-1099.
19. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinomas fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949.
20. Woo, E. Y., C. S. Chu, T. J. Goletz, K. Schlienger, R. G. Carrol, J. L. Riley, L. R. Kaiser, and C. H. June. 2002. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J. Immunol. 168: 4272-4276.
21. high regulatory T cells are overexpressed in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 173: 1444-1453.
22. Ormandy, L. A., T. Hillemann, H. Wedemeyer, M. P. Manns, T. F. Greten, and F. Korangy. 2005. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 65: 2457-2464.
23. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 293: 1295-1302.
24. 2-dependent enhancement of TIMP-1 production limits dendritic cell migration through extracellular matrix. J. Immunol. 173: 5458-5466.
25. Dohadwala, M., J. Luo, L. Zhou, Y. Lin, G. Dougherty, S. Sharma, M. Huang, M. Pold, R. K. Batra, and S. M. Dubinett. 2001. Non-small cell lung cancer cyclooxygenase-2 dependent invasion is mediated by CD44. J. Biol. Chem. 276: 20809-20812.
26. + T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J. Immunol. 171:61-68.
27. + T cells. J. Exp. Med. 194: 1711-1719.
28. Bassuny, W. M., K. Ihara, Y. Sasaki, R. Kuromaru, H. Kohno, N. Matsuura, and T. Hara. 2003. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 55: 149-156.
29. 2+ mobilization in T cells. Am. J. Physiol. 277: R1741-R1748.
30. 2-induced T-lymphocyte proliferative suppression in sepsis. Infect. Immun. 63: 3101-3105.
31. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193: 1285-1294.
32. + T cells with regulatory properties from human blood. J. Exp. Med. 193: 1303-1310.
33. Keerthisingam, C. B., R. G. Jenkins, N. K. Harrison, N. A. Hernandez-Rodriguez, H. Booth, G. J. Laurent, S. L. Hart, M. L. Foster, and R. J. McAnulty. 2001. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Physiol. 158: 1411-1422.
34. 2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4. Circ. Res. 94: 353-361.
35. + suppressor T cells. J. Exp. Med. 193: F41-F46.
36. 2 down-regulation of T cell IL-2 production is independent of IL-10 during Gram-negative sepsis. Immunol. Lett. 67: 125-130.
37. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R α gene expression at multiple levels. J. Immunol. 148: 2845.
38. fyn tyrosine kinase in T lymphocytes during sepsis. J. Immunol. 160: 929-935.
39. Nelson, B. H. 2004. IL-2, regulatory T cells, and tolerance. J. Immunol. 172: 3983-3988.
40. + regulatory T cell function. Eur. J. Immunol. 34: 2480-2488.
41. 2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin. Exp. Immunol. 127: 263-269.
42. 2 receptor expression. Hum. Immunol. 61: 684-696.
43. Benczik, M., and S. L. Gaffen. 2004. The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol. Invest. 33: 109-142.
44. Pernis, A., S. Gupta, J. Yopp, E. Garfein, H. Kashleva, C. Schindler, and P. Rothman. 1995. γ-Chain-associated cytokine receptors signal through distinct transducing factors. J. Biol. Chem. 270: 14517-14522.
45. + regulatory T cells. J. Immunol. 172: 5287-5296.
46. Jonuleit, H., and E. Schmitt. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171: 6323-6327.
47. + T cells is induced by immunosuppressive drugs and inhibited by T helper type I (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
48. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 172: 5213-5221.
49. Dannenberg, J. A., and K. Subbaramaiah. 2003. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 4: 431-436.
50. + T regulatory cell activities in lung cancer. Cancer Res. 65: 5211-5220.